Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2009
06/18/2009US20090157326 Diagnosis and prognosis of breast cancer patients
06/18/2009US20090156965 Diagnostic interlabial pad
06/18/2009US20090156687 Fab I and inhibition of apicomplexan parasites
06/18/2009US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors
06/18/2009US20090156542 MCP-1 Binding Nucleic Acids And Use Thereof
06/18/2009US20090156540 Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same
06/18/2009US20090156536 AIMP2-DX2 Gene and SiRNA Targeting AIMP2-DX2
06/18/2009US20090156532 SNP BINDING SITE FOR microRNAs IN HLA-G
06/18/2009US20090156527 Antiviral oligonucleotides targeting viral families
06/18/2009US20090156526 Compositions and methods for modulation of lmna expression
06/18/2009US20090156523 Methods and compositions for modulating foxo1 activity and insulin signaling
06/18/2009US20090156522 Pancreatic Cancer Genes
06/18/2009US20090156521 Gpr17 modulators,method of screening and uses thereof
06/18/2009US20090156506 determining Vascular Endothelial Growth Factor D (VEGF-D) concentration in a sample from human that has tuberous sclerosis complex (TSC) or a cystic or chylous lung disorder such as lymphangiomatosis, Pulmonary Langerhan's cell histiocytosis (PLCH), emphysema, Sjogren's syndrome with cystic lung disease
06/18/2009US20090156501 Identification of ligands by selective amplification of cells transfected with receptors
06/18/2009US20090156497 Non-cytotoxic PAP mutants
06/18/2009US20090156493 Urocortin-iii and uses thereof
06/18/2009US20090156475 Gene defects and mutant ALK kinase in human solid tumors
06/18/2009US20090156471 Use of anti-amyloid agents for treating and typing pathogen infections
06/18/2009US20090156467 Thymic stromal lymphpoietin promoter and use therefor
06/18/2009US20090156458 Assay for the detection of factors that modulate the expression of inagp
06/18/2009US20090156457 Methods and means for screening for rhomboid activity
06/18/2009US20090156425 Methods for detecting target analytes and enzymatic reactions
06/18/2009US20090156424 Use of mass labeled probes to detect target nucleic acids using mass spectrometry
06/18/2009US20090156420 Method for detecting cancer
06/18/2009US20090156418 Markers and methods for assessing and treating crohn's disease and related disorders
06/18/2009US20090156414 Genetic Analysis in Racing Animals
06/18/2009US20090156413 Method, system, apparatus and device for discovering and preparing chemical compounds for medical and other uses
06/18/2009US20090155917 Method for analyzing nucleobases on a single molecular basis
06/18/2009US20090155915 Biological markers for longevity and diseases and uses thereof
06/18/2009US20090155884 amino acid sequences covalent attached to retroviruses or to leukemia virus transmembrane glycoproteins; phage display libraries; drug targets
06/18/2009US20090155842 Prognostic assay for metachronous colorectal cancer
06/18/2009US20090155840 Method and device for cell counting
06/18/2009US20090155839 Method for detecting bacterial spores
06/18/2009US20090155838 Devices, systems and methods for the collection, stimulation, stabilization, and analysis of a biological sample
06/18/2009US20090155837 Two-photon fluorescent probes for acidic vesicles in live cells and tissue and method of imaging acidic vesicles in live cells and tissue using the same
06/18/2009US20090155836 Methods for treating hiv infected subjects
06/18/2009US20090155835 Diagnostic method and prognostic tool for rheumatoid arthritis
06/18/2009US20090155834 Methods for identifying agents which alter histone protein acetylation, decrease aging or increase lifespan
06/18/2009US20090155833 Screening method of nesfatin-1-action regulating substance or nesfatin-1-like action substance with the use of receptor protein selected from the group consisting of gpr3, gpr6 and gpr12
06/18/2009US20090155832 Apparatus and Method for Improved Optical Detection of Particles in Fluid
06/18/2009US20090155831 Cardiomyocytes and methods of producing and purifying cardiomyocytes
06/18/2009US20090155830 Composition and a kit for detecting early apoptosis in frozen umbilical cord and a method therefor
06/18/2009US20090155829 Heme choline esters and uses thereof
06/18/2009US20090155828 Methods of detecting prostate cancer
06/18/2009US20090155827 PIGF and FLT-1 as Prognostic Parameters for Cardiovascular Diseases
06/18/2009US20090155826 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
06/18/2009US20090155820 measuring the concentration of apoptosis-associated speck-like protein containing a caspase-associated recruitment domain (ASC); early detection
06/18/2009US20090155819 Mammalian T1R3 Sweet Taste Receptors
06/18/2009US20090155818 Measuring Receptor Homodimerization
06/18/2009US20090155816 Biosensor having nano wire for detecting food additive mono sodium glutamate and manufacturing method thereof
06/18/2009US20090155814 Proteins in type 2 diabetes
06/18/2009US20090155809 Subtractive single label comparative hybridization
06/18/2009US20090155808 Automated system for isolating, amplifying and detecting a target nucleic acid sequence
06/18/2009US20090155807 C-met mutations in lung cancer
06/18/2009US20090155806 identifying biallelic markers of a FLAP gene and the association established between these markers and diseases involving the leukotriene pathway such as asthma
06/18/2009US20090155805 Copy number alterations that predict metastatic capability of human breast cancer
06/18/2009US20090155804 Disease pathway-based method to generate biomarker panels tailored to specific therapeutics for individualized treatments
06/18/2009US20090155803 Methods for tissue analysis
06/18/2009US20090155802 Mutant DNA Polymerases with Improved Pyrophasphorolysis Activated Polymerization (PAP) Ability
06/18/2009US20090155801 Method of sequencing dna
06/18/2009US20090155800 Biosensor having nano wire and manufacturing method thereof
06/18/2009US20090155799 Methods for diagnosing pancreatic cancer using reg4 protein
06/18/2009US20090155798 Tle3 as a marker for chemotherapy
06/18/2009US20090155797 Methods For Generating Enhanced Antibody-Producing Cell Lines With Improved Growth Characteristics
06/18/2009US20090155796 Marker for cancer prognosis and methods related thereto
06/18/2009US20090155795 having relatively high coupling efficiency that are particularly useful in nucleic acid synthesis; has a redox active moiety comprising a ferrocene derivative; non-nucleotide ferrocene labels; kits
06/18/2009US20090155794 Cloning multiple control sequences into chromosomes or into artificial centromeres
06/18/2009US20090155793 Apparatus for high throughput sequencing of nucleic acids
06/18/2009US20090155792 Predictors of long-term mortality following coronary artery bypass graft surgery
06/18/2009US20090155791 Method for detecting methylation status by using methylation-independent primers
06/18/2009US20090155790 Crab-pii directed diagnostics for neoplastic disease
06/18/2009US20090155789 Genes from the 20q13 amplicon and their uses
06/18/2009US20090155788 Gene expression markers for inflammatory bowel disease
06/18/2009US20090155787 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
06/18/2009US20090155786 Compositions and methods for detecting markers of cancer
06/18/2009US20090155785 Real-time colorimetric screening inhibitors of endonuclease with gold nanoparticle substrate
06/18/2009US20090155784 Assessment of asthma and allergen-dependent gene expression
06/18/2009US20090155783 Method of preparing a biological specimen slide
06/18/2009US20090155782 Homoeologous Region Determining Method by Homo Junction Fingerprint Method, Homoeologous Region Determining Device, and Gene Screening Method
06/18/2009US20090155781 High throughput genome sequencing on DNA arrays
06/18/2009US20090155780 DNA sequencing; DNA barcoding based on direct imaging of individual DNA molecules and localization of multiple sequence motifs or polymorphic sites on a single DNA molecule
06/18/2009US20090155779 Aptamers that bind to prion protein
06/18/2009US20090155778 Mental Disorder-Related Gene and Use of the Same
06/18/2009US20090155777 Methods for performing direct enzymatic reactions involving nucleic acid molecules
06/18/2009US20090155776 for detecting the presence of or an increased risk for developing preeclampsia in a pregnant woman; positive controls for a non-invasive analytical process during which the quality and quantity of fetal DNA are monitored
06/18/2009US20090155775 Cloned dna polymerases from thermotoga and mutants thereof
06/18/2009US20090155774 Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
06/18/2009US20090155773 High-Risk Human Papillomavirus Detection
06/18/2009US20090155772 Method for detecting nanbv associated seroconversion
06/18/2009US20090155771 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
06/18/2009US20090155770 Implantable devices for fiber optic based detection of nosocomial infection
06/18/2009US20090155769 Detection method for ljungan virus
06/18/2009US20090155768 Reporter plasmid phage packaging system for detection of bacteria
06/18/2009US20090155767 Methods for a predictive diagnostic test for tamoxifen
06/18/2009US20090155766 Methods for detecting estrone by mass spectrometry
06/18/2009US20090155350 Chlamydia antigens and protein vaccine
06/18/2009US20090155312 Viral variants detection and application
06/18/2009US20090155292 Compositions and methods for the prevention and treatment of autoimmune conditions
06/18/2009US20090155278 Claudins as Markers for Early Detection, Diagnosis, Prognosis and as Targets of Therapy for Breast and Metastatic Brain or Bone Cancer